Author:
Zwang Julien,D’Alessandro Umberto,Ndiaye Jean-Louis,Djimdé Abdoulaye A,Dorsey Grant,Mårtensson Andreas A,Karema Corine,Olliaro Piero L.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, et al. Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sc. 2011;7:1427–42.
2. Krystal JE, Hansen DS, van Rooijen N, Buckingham LA, Schofield L. Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood. 2006;107:1192–9.
3. World Health Organisation: Guidelines for the treatment of malaria. Third edition (2015) http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf . Accessed 12/01/2016.
4. Finaurini S, Ronzoni L, Colancecco A, Cattaneo A, Cappellini MD, et al. Selective toxicity of dihydroartemisinin on human CD34+ erythroid cell differentiation. Toxicology. 2010;276:128–34.
5. Rehman K, Lötsch F, Kremsner PG, Ramharter M. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. Int J Infect Dis. 2014;29:268–73.